Trials / Sponsors / Taizhou EOC Pharma Co., Ltd.
Taizhou EOC Pharma Co., Ltd.
Industry · 7 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | HR Positive, HER2 Negative Advanced Breast Cancer With Progression After Endocrine Therapy Solid Tumor, Adult | Phase 2 | 2022-04-01 |
| Unknown | Telatinib in Combination With Capecitabine/ Oxaliplatin in 1st Line Gastric or GEJ Cancer Gastric Cancer | Phase 2 | 2019-01-25 |
| Completed | Phase I Study of EOC202 Plus Paclitaxel in Chinese Patients With Metastatic Breast Cancer Solid Tumor, Adult | Phase 1 | 2018-10-16 |
| Unknown | Study of EOC317 in Chinese Patients With Advanced Solid Tumors Solid Tumor | Phase 1 | 2018-05-29 |
| Unknown | Ph3 Study of Exemestane With or Without Entinostat in Chinese Patients With Hormone Receptor-Positive, Locally Advanced Breast Cancer | Phase 3 | 2018-05-15 |
| Completed | Telatinib Safety and Pharmacokinetics Study in China Patients With Advanced Solid Tumors Solid Tumor, Adult | Phase 1 | 2017-07-25 |
| Completed | Entinostat in Chinese Postmenopausal Women Patients With Locally Recurrent or Metastatic Breast Cancer Breast Cancer | Phase 1 | 2016-08-29 |